Clinical trials are the centerpiece for the drug-testing system in the United States.
Each cancer study conducted tries to answer scientific questions and determine better ways to prevent, diagnose or treat the disease. As researchers test the effectiveness of trial drugs, patients who participate, in many cases, benefit from life-saving treatment options years before they are available to the public.
As a member of The US Oncology Network, Willamette Valley Cancer Institute and Research Center offers patients access to one of the nation’s largest research networks.
“Historically, the perspective has been that in order to get the latest, greatest, most innovative care, someone has to go to a university,” says Dr. Jeff Sharman, Medical Director of Hematology for The US Oncology Network. “WVCI’s unique affiliation with The US Oncology Network enables us to bring trials to patients in Eugene.” Read more.
With skin cancer being the most common of all cancers, protecting yourself from the sun is something to think about all year long, especially on these hot, summer days. Read more.
No matter what you think of Angelina Jolie Pitt, when she talks, people listen.
That's certainly been the case since 2013 when the actress revealed in The New York Times that she is a carrier of the BRCA1 gene mutation, which fueled her decision to have a preventative double mastectomy. Read more.
There's nothing quite like the determination of the Oregon Ducks when they're looking for a win—except maybe when they're determined to show their support for their community at the same time.
The women's softball team hopes to Strike Out Cancer and the University of Washington on Saturday, March 28 at Howe Field. The team will be sporting pink in support of Oregon Cancer Foundation. Read more.
Anne Gallagher sees cancer from two perspectives—as a survivor of lung cancer, and now as a patient navigator at Willamette Valley Cancer Institute and Research Center.
For the first time, Anne is sharing her experiences with lawmakers at the state and national level to encourage continued funding for medical research and support for screening and education programs. Read more.